SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thomas W. Buford, Stephen D. Anton, David J. Clark, Torrance J. Higgins, Matthew B. Cooke, Optimizing the Benefits of Exercise on Physical Function in Older Adults, PM&R, 2014, 6, 6, 528

    CrossRef

  2. 2
    Nikolaos Samaras, Dimitrios Samaras, Emilia Frangos, Alexandre Forster, Jacques Philippe, A Review of Age-Related Dehydroepiandrosterone Decline and Its Association with Well-Known Geriatric Syndromes: Is Treatment Beneficial?, Rejuvenation Research, 2013, 16, 4, 285

    CrossRef

  3. 3
    Alexander Römmler, Josefine Römmler-Zehrer, Die Rolle des Schlüsselhormons DHEA, gynäkologie + geburtshilfe, 2013, 18, 7, 34

    CrossRef

  4. 4
    Lenka Luptákova, Daniela Siváková, Marta Cvíčelová, Effect of APOE polymorphism on obesity and lipid profile in women of differing reproductive status, Central European Journal of Biology, 2013, 8, 8, 713

    CrossRef

  5. 5
    Emmanuel Hoppé, Béatrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran, Érick Legrand, Faut-il donner des androgènes aux hommes ostéoporotiques ?, Revue du Rhumatisme, 2013, 80, 5, 446

    CrossRef

  6. 6
    Emmanuel Hoppé, Béatrice Bouvard, Mathieu Royer, Daniel Chappard, Maurice Audran, Erick Legrand, Is androgen therapy indicated in men with osteoporosis?, Joint Bone Spine, 2013, 80, 5, 459

    CrossRef

  7. 7
    J. W. Nieves, Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D, Osteoporosis International, 2013, 24, 3, 771

    CrossRef

  8. 8
    Jeri W. Nieves, Osteoporosis, 2013,

    CrossRef

  9. 9
    Cecilia Gómez-Santos, Juan José Hernández-Morante, Francisco Javier Tébar, Esteban Granero, Marta Garaulet, Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women, Clinical Endocrinology, 2012, 77, 4
  10. 10
    L Papierska, M Rabijewski, A Kasperlik-Załuska, W Zgliczyński, Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women, Advances in Medical Sciences, 2012, 57, 1, 51

    CrossRef

  11. 11
    Dennis T. Villareal, Gordon I. Smith, Krupa Shah, Bettina Mittendorfer, Effect of Weight Loss on the Rate of Muscle Protein Synthesis During Fasted and Fed Conditions in Obese Older Adults, Obesity, 2012, 20, 9
  12. 12
    Michael A. Ghebre, Deborah J. Hart, Alan J. Hakim, Bernet S. Kato, Vicky Thompson, Nigel K. Arden, Tim D. Spector, Guangju Zhai, Association between DHEAS and Bone Loss in Postmenopausal Women: A 15-Year Longitudinal Population-Based Study, Calcified Tissue International, 2011, 89, 4, 295

    CrossRef

  13. 13
    Abdulmaged M. Traish, H. Paco Kang, Farid Saad, Andre T. Guay, Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME), The Journal of Sexual Medicine, 2011, 8, 11
  14. 14
    Catherine M. Jankowski, Wendolyn S. Gozansky, Rachael E. Van Pelt, Pamela Wolfe, Robert S. Schwartz, Wendy M. Kohrt, Oral dehydroepiandrosterone replacement in older adults: effects on central adiposity, glucose metabolism and blood lipids, Clinical Endocrinology, 2011, 75, 4
  15. 15
    Victor HH Goh, Terry YY Tong, The moderating impact of lifestyle factors on sex steroids, sexual activities and aging in Asian men, Asian Journal of Andrology, 2011, 13, 4, 596

    CrossRef

  16. 16
    Catherine Jankowski, Wendy Kohrt, DHEA in Human Health and Aging, 2011,

    CrossRef

  17. 17
    Fátima Heredia, Juan Hernández-Morante, Marta Garaulet, DHEA in Human Health and Aging, 2011,

    CrossRef

  18. 18
    Alessandro Genazzani, Chiara Lanzoni, DHEA in Human Health and Aging, 2011,

    CrossRef

  19. 19
    Anne M. Kenny, Rebecca S. Boxer, Alison Kleppinger, Jennifer Brindisi, Richard Feinn, Joseph A. Burleson, Dehydroepiandrosterone Combined with Exercise Improves Muscle Strength and Physical Function in Frail Older Women, Journal of the American Geriatrics Society, 2010, 58, 9
  20. 20
    Stefanie Hahner, Bruno Allolio, Dehydroepiandrosterone to Enhance Physical Performance: Myth and Reality, Endocrinology and Metabolism Clinics of North America, 2010, 39, 1, 127

    CrossRef

  21. 21
    Mary Panjari, Susan R. Davis, DHEA for postmenopausal women: A review of the evidence, Maturitas, 2010, 66, 2, 172

    CrossRef

  22. 22
    R. S. Boxer, A. Kleppinger, J. Brindisi, R. Feinn, J. A. Burleson, A. M. Kenny, Effects of dehydroepiandrosterone (DHEA) on cardiovascular risk factors in older women with frailty characteristics, Age and Ageing, 2010, 39, 4, 451

    CrossRef

  23. 23
    Eda Özçelik, Sema Uslu, Nur Kebapçı, Mehmet Kara, Ali Dokumacıoğlu, Ahmet Musmul, Interrelations of serum leptin levels with adrenocorticotropic hormone, basal cortisol and dehydroepiandrosterone sulphate levels in patients with metabolic syndrome, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2010, 4, 1, 13

    CrossRef

  24. 24
    Liesbeth Vandenput, Claes Ohlsson, Sex steroid metabolism in the regulation of bone health in men, The Journal of Steroid Biochemistry and Molecular Biology, 2010, 121, 3-5, 582

    CrossRef

  25. 25
    Fernand Labrie, Neuroendocrinology - Pathological Situations and Diseases, 2010,

    CrossRef

  26. 26
    Bart L. Clarke, Sundeep Khosla, Androgens and bone, Steroids, 2009, 74, 3, 296

    CrossRef

  27. 27
    Ewa A. Jankowska, Justyna Jakubaszko, Aldona Cwynar, Jacek Majda, Beata Ponikowska, Dorota Kustrzycka-Kratochwil, Krzysztof Reczuch, Ludmila Borodulin-Nadzieja, Waldemar Banasiak, Philip A. Poole-Wilson, Piotr Ponikowski, Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants, European Journal of Heart Failure, 2009, 11, 1
  28. 28
    Yan Li, Zunen Xia, Ming Wang, Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma, International Immunopharmacology, 2009, 9, 2, 168

    CrossRef

  29. 29
    L. Wang, Y.-D. Wang, W.-J. Wang, D.-J. Li, Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice, Osteoporosis International, 2009, 20, 1, 79

    CrossRef

  30. 30
    Myoung-Ae Choe, Gyeong-Ju An, Effect of DHEA Administration Alone or Exercise combined with DHEA before Steroid Treatment on Rat Hindlimb Muscles, Journal of Korean Academy of Nursing, 2009, 39, 3, 321

    CrossRef

  31. 31
    Mary Panjari, Robin J. Bell, Fiona Jane, Jenny Adams, Corallee Morrow, Susan R. Davis, The safety of 52 weeks of oral DHEA therapy for postmenopausal women, Maturitas, 2009, 63, 3, 240

    CrossRef

  32. 32
    Hiroko Hosoda, Michiaki Fukui, Ichiko Nakayama, Mai Asano, Mayuko Kadono, Goji Hasegawa, Toshikazu Yoshikawa, Naoto Nakamura, Bone mass and bone resorption in postmenopausal women with type 2 diabetes mellitus, Metabolism, 2008, 57, 7, 940

    CrossRef

  33. 33
    Sumit Bhagra, Todd B Nippoldt, K Sreekumaran Nair, Dehydroepiandrosterone in adrenal insufficiency and ageing, Current Opinion in Endocrinology, Diabetes and Obesity, 2008, 15, 3, 239

    CrossRef

  34. 34
    D. von Mühlen, G. A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, R. Bettencourt, Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial, Osteoporosis International, 2008, 19, 5, 699

    CrossRef

  35. 35
    Krisztián Bácsi, János Kósa, Áron Lazáry, Henrik Horváth, Bernadett Balla, Péter Lakatos, Gábor Speer, A dehidroepiandroszteron és dehidroepiandroszteron-szulfát jelentôsége különböző kórállapotokban, Orvosi Hetilap, 2007, 148, 14, 651

    CrossRef

  36. 36
    Ellen M. Evans, Susan B. Racette, Rachael E. Van Pelt, Linda R. Peterson, Dennis T. Villareal, Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women, Menopause, 2007, 14, 3, 481

    CrossRef

  37. 37
    Victor H. H. Goh, Terry Y. Y. Tong, Helen P. P. Mok, Baharudin Said, Interactions among age, adiposity, bodyweight, lifestyle factors and sex steroid hormones in healthy Singaporean Chinese men, Asian Journal of Andrology, 2007, 9, 5
  38. 38
    Alessandro D Genazzani, Chiara Lanzoni, Andrea R Genazzani, Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly?, Drugs & Aging, 2007, 24, 3, 173

    CrossRef

  39. 39
    Paul S. Dudley, John E. Duster, Treatment of the Postmenopausal Woman, 2007,

    CrossRef

  40. 40
    Masao Yukioka, Yoshio Komatsubara, Kazuhiko Yukioka, Tomoko Toyosaki-Maeda, Kazuo Yonenobu, Takahiro Ochi, Adrenocorticotropic hormone and dehydroepiandrosterone sulfate levels of rheumatoid arthritis patients treated with glucocorticoids, Modern Rheumatology, 2006, 16, 1, 30

    CrossRef

  41. 41
    Masao Yukioka, Yoshio Komatsubara, Kazuhiko Yukioka, Tomoko Toyosaki-Maeda, Kazuo Yonenobu, Takahiro Ochi, Adrenocorticotropic hormone and dehydroepiandrosterone sulfate levels of rheumatoid arthritis patients treated with glucocorticoids, Modern Rheumatology, 2006, 16, 1, 30

    CrossRef

  42. 42
    Wiebke Arlt, Dehydroepiandrosterone replacement therapy, Current Opinion in Endocrinology and Diabetes, 2006, 13, 3, 291

    CrossRef

  43. 43
    K. Sreekumaran Nair, Robert A. Rizza, Peter O'Brien, Ketan Dhatariya, Kevin R. Short, Ajay Nehra, Janet L. Vittone, George G. Klee, Ananda Basu, Rita Basu, Claudio Cobelli, Gianna Toffolo, Chiara Dalla Man, Donald J. Tindall, L. Joseph Melton, Glenn E. Smith, Sundeep Khosla, Michael D. Jensen, DHEA in Elderly Women and DHEA or Testosterone in Elderly Men, New England Journal of Medicine, 2006, 355, 16, 1647

    CrossRef

  44. 44
    Ingrid Kohlstadt, Vilma Joseph, Scientific Evidence for Musculoskeletal, Bariatric, and Sports Nutrition, 2006,

    CrossRef

  45. 45
    Mohamed S. Ahmed, Brittany Matsumura, Adrian Cristian, Age-related changes in muscles and joints, Physical Medicine and Rehabilitation Clinics of North America, 2005, 16, 1, 19

    CrossRef

  46. 46
    Analia Tomova, Philip Kumanov, Are dehydroepiandrosterone sulphate and lipids associated with erectile dysfunction?, Maturitas, 2005, 50, 4, 294

    CrossRef

  47. 47
    &NA;, Dehydroepiandrosterone (DHEA), Obstetrics & Gynecology, 2005, 106, 5, Part 1, 1096

    CrossRef

  48. 48
    Irene Lambrinoudaki, George Christodoulakos, Leon Aravantinos, Aristidis Antoniou, Demetrios Rizos, Constantinos Chondros, Apostolos Kountouris, Grigorios Chrysofakis, George Creatsas, Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women, Journal of Bone and Mineral Metabolism, 2005, 24, 1, 65

    CrossRef

  49. 49
    A. Frisoli, P. H. M. Chaves, M. M. Pinheiro, V. L. Szejnfeld, The Effect of Nandrolone Decanoate on Bone Mineral Density, Muscle Mass, and Hemoglobin Levels in Elderly Women With Osteoporosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2005, 60, 5, 648

    CrossRef

  50. 50
    Crista E Johnson, Jennifer R Berman, The role of androgens in hormone replacement therapy, Expert Opinion on Pharmacotherapy, 2005, 6, 11, 1815

    CrossRef

  51. 51
    Deborah R Cameron, Glenn D Braunstein, The Use of Dehydroepiandrosterone Therapy in Clinical Practice, Treatments in Endocrinology, 2005, 4, 2, 95

    CrossRef

  52. 52
    Helen Karakelides, K. Sreekumaran Nair, 2005,

    CrossRef

  53. 53
    Henry Lardy, Ashok Marwah, Padma Marwah, 2005,

    CrossRef

  54. 54
    H. Blain, A. Vuillemin, A. Blain, F. Guillemin, N. D. Talance, B. Doucet, C. Jeandel, Age-Related Femoral Bone Loss in Men: Evidence for Hyperparathyroidism and Insulin-Like Growth Factor-1 Deficiency, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2004, 59, 12, 1285

    CrossRef

  55. 55
    Wiebke Arlt, Dehydroepiandrosterone and ageing, Best Practice & Research Clinical Endocrinology & Metabolism, 2004, 18, 3, 363

    CrossRef

  56. 56
    Mohamad H Horani, John E Morley, Hormonal fountains of youth, Clinics in Geriatric Medicine, 2004, 20, 2, 275

    CrossRef

  57. 57
    Élisabeth Fontanges, Aurélie Fontana, Pierre Delmas, Ostéoporose et cancer du sein, Revue du Rhumatisme, 2004, 71, 3, 187

    CrossRef

  58. 58
    Elisabeth Fontanges, Aurélie Fontana, Pierre Delmas, Osteoporosis and breast cancer, Joint Bone Spine, 2004, 71, 2, 102

    CrossRef

  59. 59
    Ekrem C Tok, Devrim Ertunc, Utku Oz, Handan Camdeviren, Gulay Ozdemir, Saffet Dilek, The effect of circulating androgens on bone mineral density in postmenopausal women, Maturitas, 2004, 48, 3, 235

    CrossRef

  60. 60
    Tori Hudson, Alternative Medicine and Women's Health Issues, Alternative and Complementary Therapies, 2003, 9, 3, 136

    CrossRef

  61. 61
    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR THE CLINICAL USE OF DIETARY SUPPLEMENTS AND NUTRACEUTICALS, Endocrine Practice, 2003, 9, 5, 417

    CrossRef

  62. 62
    C. Marcelli, Can DHEA be used to prevent bone loss and osteoporosis?, Joint Bone Spine, 2003, 70, 1, 1

    CrossRef

  63. 63
    Ketan K. Dhatariya, K. Sreekumaran Nair, Dehydroepiandrosterone: Is There a Role for Replacement?, Mayo Clinic Proceedings, 2003, 78, 10, 1257

    CrossRef

  64. 64
    C Marcelli, La DHEA est-elle un traitement préventif de la perte osseuse et de l’ostéoporose ?, Revue du Rhumatisme, 2003, 70, 1, 1

    CrossRef

  65. 65
    Craig S Atwood, Nir Barzilai, Richard L Bowen, Holly M Brown-Borg, David F Jarrard, Vivian X Fu, Leonie K Heilbronn, Donald K Ingram, Eric Ravussin, Robert S Schwartz, Richard Weindruch, Pennington Scientific Symposium on Mechanisms and Retardation of Aging, Experimental Gerontology, 2003, 38, 10, 1217

    CrossRef

  66. 66
    Sylvie Legrain, Laurence Girard, Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects, Drugs & Aging, 2003, 20, 13, 949

    CrossRef

  67. 67
    A. M. Isidori, G. A. Kaltsas, L. Perry, J. M. Burrin, G. M. Besser, J. P. Monson, The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism, Clinical Endocrinology, 2003, 58, 5
  68. 68
    Richard F Spark, Dehydroepiandrosterone: a springboard hormone for female sexuality, Fertility and Sterility, 2002, 77, 19

    CrossRef

  69. 69
    J.L Schlienger, A.E Perrin, B Goichot, DHEA : célèbre et méconnue, La Revue de Médecine Interne, 2002, 23, 5, 436

    CrossRef

  70. 70
    Bruno Allolio, Wiebke Arlt, DHEA treatment: myth or reality?, Trends in Endocrinology & Metabolism, 2002, 13, 7, 288

    CrossRef

  71. 71
    Dennis T. Villareal, Effects of Dehydroepiandrosterone on Bone Mineral Density, Treatments in Endocrinology, 2002, 1, 6, 349

    CrossRef

  72. 72
    Sandra L. Welner, James A. Simon, Barbara Welner, Maximizing health in menopausal women with disabilities, Menopause, 2002, 9, 3, 208

    CrossRef

  73. 73
    Anti-Aging Medicine LiteratureWatch, Journal of Anti-Aging Medicine, 2001, 4, 1, 75

    CrossRef

  74. 74
    Wiebke Arlt, Bruno Allolio, Dehydroepiandrosterone replacement therapy, Current Opinion in Endocrinology & Diabetes, 2001, 8, 3, 130

    CrossRef

  75. 75
    Catherine Cormier, Jean-Claude Souberbielle, André Kahan, DHEA et pathologie ostéoarticulaire, Revue du Rhumatisme, 2001, 68, 10-11, 958

    CrossRef

  76. 76
    Catherine Cormier, Jean-Claude Souberbielle, André Kahan, DHEA in bone and joint diseases, Joint Bone Spine, 2001, 68, 6, 588

    CrossRef

  77. 77
    Shehzad Basaria, Adrian S Dobs, Hypogonadism and androgen replacement therapy in elderly men, The American Journal of Medicine, 2001, 110, 7, 563

    CrossRef

  78. 78
    OMID KHORRAM, Potential Therapeutic Effects of Prescribed and Over-the-Counter Androgens in Women, Clinical Obstetrics and Gynecology, 2001, 44, 4, 880

    CrossRef